Tag: mitral regurgitation

Approval of Tendyne TMVI device means physicians now have a portfolio...

Abbott made history in January when it became the first company in the world to receive market approval for a transcatheter mitral valve implantation...
Cardiovalve

Cardiovalve receives Breakthrough Device Designation for its transcatheter tricuspid valve replacement...

Cardiovalve has received US Food and Drug Administration (FDA) approval for an early feasibility study (EFS) of its transcatheter tricuspid valve replacement system for...

“Our goal is to treat more patients with mitral regurgitation”

Last month, Abbott announced US Food and Drug Administration (FDA) approval of a new trial—REPAIR MR—to evaluate the safety and efficacy of percutaneous edge-to-edge...

Abbott gets green light for trial on MitraClip in moderate surgical...

Abbott has announced that the US Food and Drug Administration (FDA) has approved a first-of-its-kind clinical trial that will compare the effectiveness of Abbott's...

PCR London Valves 2019: One-year survival better with Mitra Clip than...

A single-centre real world experience has found that the vast majority of patients with severe mitral regurgitation (MR) were not eligible for inclusion in...

Carillon Mitral Contour System reaches 1,000 implants for functional mitral regurgitation

  Cardiac Dimensions has announced in a press release that its Carillon Mitral Contour System has now been implanted in 1,000 patients in the USA,...

PASCAL poised to rival MitraClip for safety and efficacy

PASCAL’s (Edwards Lifesciences) safety and efficacy may rival that of MitraClip (Abbott) for the treatment of mitral regurgitation (MR), according to data published in...

Boston Scientific exercises option to acquire Millipede

Boston Scientific has exercised its option to acquire the remaining shares of Millipede, upon its recent successful completion of a first-in-human clinical study. The...

ESC 2018: MitraClip makes “absolutely no difference” for the prognosis...

The first randomised controlled trial to compare percutaneous edge-to-edge repair (MitraClip, Abbott) with medical therapy alone in patients with secondary mitral regurgitation (to heart...

Controlling blood pressure may help to prevent mitral regurgitation

A new study indicates that long-term exposure to elevated blood pressure is associated with an increased risk of primary and secondary mitral regurgitation. According...

Neovasc provides Tiara clinical update

Neovasc has provided an update on the study progress and clinical performance of the Tiara valve, a self-expanding mitral bioprosthesis for transcatheter implantation in...

4C Medical receives over US$8 million financing for transcatheter mitral regurgitation...

4C Medical has received approximately US$9 million in unsecured convertible promissory notes. The company is focused on the development of minimally invasive therapies for...

Second successful annuloplasty performed using Micro Interventional Devices minimally invasive technology

The second clinical case using Micro Interventional Devices’ proprietary MIA (minimally invasive annuloplasty) technology for percutaneous mitral and tricuspid repair has been performed on...

Patient with tricuspid regurgitation successfully treated with world’s first transcatheter tricuspid...

NaviGate Cardiac Structures has announced that a novel valved stent that can capture the enlarged annulus in patients with functional tricuspid regurgitation was successfully...

FDA grant Cardiac Dimensions investigational device exemption approval to conduct study

Cardiac Dimensions has received FDA approval for its investigational device exemption (IDE) CARILLON trial. The multicentre, blinded, randomised controlled trial is designed to evaluate...